1.Preface
1.1.Report Description
1.1.1.Purpose of the Report
1.1.2.Target Audience
1.1.3.USP and Key Offerings
1.2.Research Scope
1.3.Research Methodology
1.3.1.Phase I – Secondary Research
1.3.2.Phase II – Primary Research
1.3.3.Phase III – Expert Panel Review
1.3.4.Approach Adopted
1.3.4.1.Top-Down Approach
1.3.4.2.Bottom-Up Approach
1.3.5.Assumptions
1.4.Market Segmentation
2.Executive Summary
2.1.Market Snapshot: Global ADHD Drugs Market
3.Market Dynamics
3.1.Introduction
3.1.1. Global ADHD Drugs Market Value, 2015-2027, (US$ Bn)
3.2.Market Dynamics
3.2.1.Key Growth Trends
3.2.2.Major Industry Challenges
3.2.3.Key Growth Pockets
3.3.Attractive Investment Proposition,2020
3.3.1.Drug Type
3.3.2.Age-Group
3.3.3.Distribution Channel
3.3.4.Geography
4.Market Positioning of Key Players, 2020
4.1.Company market share of key players, 2020
4.2.Top 6 Players
4.3.Top 3 Players
4.4.Major Strategies Adopted by Key Players
5.COVID 19 Impact Analysis
5.1.Global ADHD Drugs Market Pre Vs Post COVID 19, 2019 – 2027
5.2.Impact on Import & Export
5.3.Impact on Demand & Supply
6.North America
6.1.North America ADHD Drugs Market, by Country, 2015-2027(US$ Bn)
6.1.1.U.S.
6.1.2.Canada
6.1.3.Mexico
6.2.North America ADHD Drugs Market, by Drug Type, 2015-2027(US$ Bn)
6.2.1.Overview
6.2.2.Stimulant
6.2.3.Non-stimulant
6.3.North America ADHD Drugs Market, By Age-Group, 2015-2027(US$ Bn)
6.3.1.Overview
6.3.2.Adult (Aged 18 and above)
6.3.3.Children
6.4.North America ADHD Drugs Market, by Distribution Channel, 2015-2027(US$ Bn)
6.4.1.Overview
6.4.2.Retail Pharmacy
6.4.3.Hospital Pharmacy
7.Europe
7.1.Europe ADHD Drugs Market, by Country, 2015-2027(US$ Bn)
7.1.1.UK
7.1.2.France
7.1.3.Germany
7.1.4.Italy
7.1.5.Russia
7.1.6.Spain
7.1.7.Belgium
7.1.8.Netherland
7.1.9.Austria
7.1.10.Sweden
7.1.11.Poland
7.1.12.Denmark
7.1.13.Switzerland
7.1.14.Rest of Europe
7.2.Europe ADHD Drugs Market, by Drug Type, 2015-2027(US$ Bn)
7.2.1.Overview
7.2.2.Stimulant
7.2.3.Non-stimulant
7.3.Europe ADHD Drugs Market, By Age-Group, 2015-2027(US$ Bn)
7.3.1.Overview
7.3.2.Adult (Aged 18 and above)
7.3.3.Children
7.4.Europe ADHD Drugs Market, by Distribution Channel, 2015-2027(US$ Bn)
7.4.1.Overview
7.4.2.Retail Pharmacy
7.4.3.Hospital Pharmacy
8.Asia Pacific
8.1.Asia Pacific ADHD Drugs Market, by Country, 2015-2027(US$ Bn)
8.1.1.China
8.1.2.Japan
8.1.3.South Korea
8.1.4.India
8.1.5.Australia
8.1.6.New Zealand
8.1.7.Taiwan
8.1.8.Southeast Asia
8.1.9.Central Asia
8.1.10.Rest of Asia Pacific
8.2.Asia Pacific ADHD Drugs Market, by Drug Type, 2015-2027(US$ Bn)
8.2.1.Overview
8.2.2.Stimulant
8.2.3.Non-stimulant
8.3.Asia Pacific ADHD Drugs Market, By Age-Group, 2015-2027(US$ Bn)
8.3.1.Overview
8.3.2.Adult (Aged 18 and above)
8.3.3.Children
8.4.Asia Pacific ADHD Drugs Market, by Distribution Channel, 2015-2027(US$ Bn)
8.4.1.Overview
8.4.2.Retail Pharmacy
8.4.3.Hospital Pharmacy
9.Latin America
9.1.Latin America ADHD Drugs Market, by Country, 2015-2027(US$ Bn)
9.1.1.Brazil
9.1.2.Argentina
9.1.3.Peru
9.1.4.Chile
9.1.5.Colombia
9.1.6.Rest of Latin America
9.2.Latin America ADHD Drugs Market, by Drug Type, 2015-2027(US$ Bn)
9.2.1.Overview
9.2.2.Stimulant
9.2.3.Non-stimulant
9.3.Latin America ADHD Drugs Market, By Age-Group, 2015-2027(US$ Bn)
9.3.1.Overview
9.3.2.Adult (Aged 18 and above)
9.3.3.Children
9.4.Latin America ADHD Drugs Market, by Distribution Channel, 2015-2027(US$ Bn)
9.4.1.Overview
9.4.2.Retail Pharmacy
9.4.3.Hospital Pharmacy
10.Middle East
10.1.Middle East ADHD Drugs Market, by Country, 2015-2027(US$ Bn)
10.1.1.UAE
10.1.2.KSA
10.1.3.Israel
10.1.4.Turkey
10.1.5.Iran
10.1.6.Rest of Middle East
10.2.Middle East ADHD Drugs Market, by Drug Type, 2015-2027(US$ Bn)
10.2.1.Overview
10.2.2.Stimulant
10.2.3.Non-stimulant
10.3.Middle East ADHD Drugs Market, By Age-Group, 2015-2027(US$ Bn)
10.3.1.Overview
10.3.2.Adult (Aged 18 and above)
10.3.3.Children
10.4.Middle East ADHD Drugs Market, by Distribution Channel, 2015-2027(US$ Bn)
10.4.1.Overview
10.4.2.Retail Pharmacy
10.4.3.Hospital Pharmacy
11.Africa
11.1.Africa ADHD Drugs Market, by Country, 2015-2027(US$ Bn)
11.1.1.South Africa
11.1.2.Egypt
11.1.3.Nigeria
11.1.4.Rest of Africa
11.2.Africa ADHD Drugs Market, by Drug Type, 2015-2027(US$ Bn)
11.2.1.Overview
11.2.2.Stimulant
11.2.3.Non-stimulant
11.3.Africa ADHD Drugs Market, By Age-Group, 2015-2027(US$ Bn)
11.3.1.Overview
11.3.2.Adult (Aged 18 and above)
11.3.3.Children
11.4.Africa ADHD Drugs Market, by Distribution Channel, 2015-2027(US$ Bn)
11.4.1.Overview
11.4.2.Retail Pharmacy
11.4.3.Hospital Pharmacy
12.Global
12.1.Global ADHD Drugs Market, by Drug Type, 2015-2027(US$ Bn)
12.1.1.Overview
12.1.2.Stimulant
12.1.3.Non-stimulant
12.2.Global ADHD Drugs Market, By Age-Group, 2015-2027(US$ Bn)
12.2.1.Overview
12.2.2.Adult (Aged 18 and above)
12.2.3.Children
12.3.Global ADHD Drugs Market, by Distribution Channel, 2015-2027(US$ Bn)
12.3.1.Overview
12.3.2.Retail Pharmacy
12.3.3.Hospital Pharmacy
13.Company Profiles
13.1.Amneal Pharmaceuticals, Inc
13.2.Eli Lilly And Company
13.3.Janssen Pharmaceuticals, Inc
13.4.Noven Pharmaceuticals, Inc
13.5.RespireRx Pharmaceuticals Inc
13.6.Otsuka Pharmaceutical Co., Ltd
13.7.Neos Therapeutics, Inc.
13.8.American Brivision (Holding) Corporation
13.9.Novartis International AG
13.10.Takeda Pharmaceutical Company Limited
13.11.GlaxoSmithKline plc
13.12.Purdue Pharma L.P
List of Figures
FIG. 1 Global ADHD Drugs Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global ADHD Drugs Market Segmentation
FIG. 4 Global ADHD Drugs Market, by Product, 2019 (US$ Bn)
FIG. 5 Global ADHD Drugs Market, by End-user, 2019 (US$ Bn)
FIG. 6 Global ADHD Drugs Market, by Geography, 2019 (US$ Bn)
FIG. 7 Attractive Investment Proposition, by Geography, 2019
FIG. 8 Global Market Positioning of Key ADHD Drugs Market Manufacturers, 2019
FIG. 9 Global ADHD Drugs Market Value Contribution, By Drug Type, 2019 & 2027 (Value %)
FIG. 10 Global ADHD Drugs Market, by Metal 1, Value, 2015-2027 (US$ Bn)
FIG. 11 Global ADHD Drugs Market, by Metal 2, Value, 2015-2027 (US$ Bn)
FIG. 12 Global ADHD Drugs Market, by Metal 3, Value, 2015-2027 (US$ Bn)
FIG. 13 Global ADHD Drugs Market, by Metal 4, Value, 2015-2027 (US$ Bn)
FIG. 14 Global ADHD Drugs Market, by Metal 5, Value, 2015-2027 (US$ Bn)
FIG. 15 Global ADHD Drugs Market, by Others, Value, 2015-2027 (US$ Bn)
FIG. 16 Global ADHD Drugs Market Value Contribution, By Age-Group, 2019 & 2027 (Value %)
FIG. 17 Global ADHD Drugs Market, by Process 1, Value, 2015-2027 (US$ Bn)
FIG. 18 Global ADHD Drugs Market, by Process 2, Value, 2015-2027 (US$ Bn)
FIG. 19 Global ADHD Drugs Market, by Process 3, Value, 2015-2027 (US$ Bn)
FIG. 20 U.S. ADHD Drugs Market, 2015-2027 (US$ Bn)
FIG. 21 Rest of North America ADHD Drugs Market, 2015-2027 (US$ Bn)
FIG. 22 U.K. ADHD Drugs Market, 2015-2027 (US$ Bn)
FIG. 23 Germany ADHD Drugs Market, 2015-2027 (US$ Bn)
FIG. 24 France ADHD Drugs Market, 2015-2027 (US$ Bn)
FIG. 25 Rest of Europe ADHD Drugs Market, 2015-2027 (US$ Bn)
FIG. 26 Japan ADHD Drugs Market, 2015-2027 (US$ Bn)
FIG. 27 China ADHD Drugs Market, 2015-2027 (US$ Bn)
FIG. 28 India ADHD Drugs Market, 2015-2027 (US$ Bn)
FIG. 29 Rest of Asia Pacific ADHD Drugs Market, 2015-2027 (US$ Bn)
FIG. 30 Middle East & Africa ADHD Drugs Market, 2015-2027 (US$ Bn)
FIG. 31 Latin America ADHD Drugs Market, 2015-2027 (US$ Bn)
List of Tables
TABLE 1 Market Snapshot: Global ADHD Drugs Market
TABLE 2 Global ADHD Drugs Market, by Drug Type, 2015-2027 (US$ Bn)
TABLE 3 Global ADHD Drugs Market, by Age-Group, 2015-2027 (US$ Bn)
TABLE 4 Global ADHD Drugs Market, by Distribution Channel, 2015-2027 (US$ Bn)
TABLE 5 Global ADHD Drugs Market, by Geography, 2015-2027 (US$ Bn)
TABLE 6 North America ADHD Drugs Market, by Drug Type, 2015-2027 (US$ Bn)
TABLE 7 North America ADHD Drugs Market, by Age-Group, 2015-2027 (US$ Bn)
TABLE 8 North America ADHD Drugs Market, by Country, 2015-2027 (US$ Bn)
TABLE 9 Europe ADHD Drugs Market, by Drug Type, 2015-2027 (US$ Bn)
TABLE 10 Europe ADHD Drugs Market, by Age-Group, 2015-2027 (US$ Bn)
TABLE 11 Europe ADHD Drugs Market, by Country/Region, 2015-2027 (US$ Bn)
TABLE 12 Asia Pacific ADHD Drugs Market, by Drug Type, 2015-2027 (US$ Bn)
TABLE 13 Asia Pacific ADHD Drugs Market, by Age-Group, 2015-2027 (US$ Bn)
TABLE 14 Asia Pacific ADHD Drugs Market, by Country/Region, 2015-2027 (US$ Bn)
TABLE 15 Latin America ADHD Drugs Market, by Drug Type, 2015-2027 (US$ Bn)
TABLE 16 Latin America ADHD Drugs Market, by Age-Group, 2015-2027 (US$ Bn)
TABLE 17 Latin America ADHD Drugs Market, by Country/Region, 2015-2027 (US$ Bn)
TABLE 18 Middle East ADHD Drugs Market, by Drug Type, 2015-2027 (US$ Bn)
TABLE 19 Middle East ADHD Drugs Market, by Age-Group, 2015-2027 (US$ Bn)
TABLE 20 Middle East ADHD Drugs Market, by Country/Region, 2015-2027 (US$ Bn)
TABLE 21 Africa ADHD Drugs Market, by Drug Type, 2015-2027 (US$ Bn)
TABLE 22 Africa ADHD Drugs Market, by Age-Group, 2015-2027 (US$ Bn)
TABLE 23 Africa ADHD Drugs Market, by Country/Region, 2015-2027 (U$ Bn)
TABLE 24 Amneal Pharmaceuticals, Inc: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 25 Eli Lilly And Company: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 26 Janssen Pharmaceuticals, Inc,: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 27 Noven Pharmaceuticals, Inc,: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 28 RespireRx Pharmaceuticals Inc,: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 29 Otsuka Pharmaceutical Co., Ltd: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 30 , Neos Therapeutics, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 31 American Brivision (Holding) Corporation: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 32 Novartis International AG: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 33 Takeda Pharmaceutical Company Limited: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 34 GlaxoSmithKline plc: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 35 Purdue Pharma L.P: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments